ADMA Biologics
ADMA
ADMA
88 hedge funds and large institutions have $137M invested in ADMA Biologics in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
70% less call options, than puts
Call options by funds: $632K | Put options by funds: $2.12M
Holders
88
Holding in Top 10
2
Calls
$632K
Puts
$2.12M
Top Buyers
| 1 | +$14M | |
| 2 | +$8.92M | |
| 3 | +$7.9M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$7.27M |
| 5 |
AIC
AWM Investment Company
New York
|
+$6.46M |
Top Sellers
| 1 | -$1.87M | |
| 2 | -$716K | |
| 3 | -$583K | |
| 4 |
Morgan Stanley
New York
|
-$462K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$344K |